Atlas Trials

A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years

Clinical trial NCT02696148 · COMPLETED

Trial details

NCT number
NCT02696148
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metabolism and Nutrition DisorderObesity
Start date
2016-03-14
Primary completion
2017-04-13
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.